<table id="table7" width="100%" xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<caption>Table 7: Drug Interactions: Changes in Pharmacokinetic Parameters for Nelfinavir in the Presence of the Coadministered Drug</caption>
<col align="left" valign="top" width="22%"></col>
<col align="left" valign="top" width="22%"></col>
<col align="center" valign="top" width="5%"></col>
<col align="center" valign="top" width="17%"></col>
<col align="center" valign="top" width="17%"></col>
<col align="center" valign="top" width="17%"></col>
<thead>
<tr>
<th stylecode="Lrule Rrule"></th>
<th stylecode="Rrule"></th>
<th stylecode="Rrule"></th>
<th colspan="3" stylecode="Rrule Botrule">% Change of Nelfinavir Pharmacokinetic Parameters<footnote>↑ Indicates increase ↓ Indicates decrease ↔ Indicates no change (geometric mean exposure increased or decreased &lt; 10%)</footnote> (90% CI)</th>
</tr>
<tr stylecode="Botrule">
<th stylecode="Lrule Rrule">Coadministered Drug</th>
<th align="center" stylecode="Rrule">Nelfinavir Dose</th>
<th stylecode="Rrule">N</th>
<th stylecode="Rrule">AUC</th>
<th stylecode="Rrule">C<sub>max</sub>
</th>
<th stylecode="Rrule">C<sub>min</sub>
</th>
</tr>
</thead>
<tfoot>
<tr>
<td align="left" colspan="6">NA: Not relevant for single-dose treatment</td>
</tr>
</tfoot>
<tbody>
<tr stylecode="Botrule">
<td colspan="6" stylecode="Lrule Rrule">HIV-Protease Inhibitors</td>
</tr>
<tr>
<td stylecode="Lrule Rrule">Indinavir 800 mg q8h × 7 days</td>
<td stylecode="Rrule">750 mg Single Dose</td>
<td stylecode="Rrule">6</td>
<td stylecode="Rrule">↑83%<br/>(↑42–↑137%)</td>
<td stylecode="Rrule">↑31%<br/>(↑16–↑48%)</td>
<td stylecode="Rrule">NA</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule Toprule">Ritonavir 500 mg q12h × 3 doses</td>
<td stylecode="Rrule Toprule">750 mg Single Dose</td>
<td stylecode="Rrule Toprule">10</td>
<td stylecode="Rrule Toprule">↑152%<br/>(↑96–↑224%)</td>
<td stylecode="Rrule Toprule">↑44%<br/>(↑28–↑63%)</td>
<td stylecode="Rrule Toprule">NA</td>
</tr>
<tr>
<td stylecode="Lrule Rrule">Saquinavir 1200 mg tid × 4 days <footnote>Using the soft-gelatin capsule formulation of saquinavir 1200 mg</footnote>
</td>
<td stylecode="Rrule">750 mg Single Dose</td>
<td stylecode="Rrule">14</td>
<td stylecode="Rrule">↑18%<br/>(↑7–↑30%)</td>
<td stylecode="Rrule">↔</td>
<td stylecode="Rrule">NA</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule Toprule">Amprenavir 800 mg tid × 14 days</td>
<td stylecode="Rrule Toprule">750 mg tid × 14 days</td>
<td stylecode="Rrule Toprule">6</td>
<td colspan="3" stylecode="Rrule Toprule">See footnote <footnote id="t6ft1">Based on non-definitive cross-study comparison, nelfinavir plasma concentrations appeared to be unaffected by coadministration</footnote>
</td>
</tr>
<tr stylecode="Botrule">
<td colspan="6" stylecode="Lrule Rrule">Nucleoside Reverse Transcriptase Inhibitors</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule">Didanosine 200 mg Single Dose</td>
<td stylecode="Rrule">750 mg Single Dose</td>
<td stylecode="Rrule">9</td>
<td stylecode="Rrule">↔</td>
<td stylecode="Rrule">↔</td>
<td stylecode="Rrule">NA</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule">Zidovudine 200 mg + Lamivudine 150 mg Single Dose</td>
<td stylecode="Rrule">750 mg q8h × 7–10 days</td>
<td stylecode="Rrule">11</td>
<td stylecode="Rrule">↔</td>
<td stylecode="Rrule">↔</td>
<td stylecode="Rrule">↔</td>
</tr>
<tr stylecode="Botrule">
<td colspan="6" stylecode="Lrule Rrule">Non-Nucleoside Reverse Transcriptase Inhibitors</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule">Efavirenz 600 mg qd × 7 days</td>
<td stylecode="Rrule">750 mg q8h × 7 days</td>
<td stylecode="Rrule">7</td>
<td stylecode="Rrule">↑20%<br/>(↑8–↑34%)</td>
<td stylecode="Rrule">↑21%<br/>(↑10–↑33%)</td>
<td stylecode="Rrule">↔</td>
</tr>
<tr>
<td stylecode="Lrule Rrule">Nevirapine 200 mg qd × 14 days<br/>Followed by 200 mg bid × 14 days</td>
<td stylecode="Rrule">750 mg tid × 36 days</td>
<td stylecode="Rrule">23</td>
<td stylecode="Rrule">↔</td>
<td stylecode="Rrule">↔</td>
<td stylecode="Rrule">↓32%<br/>(↓50–↑5%)</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule Toprule">Delavirdine 400 mg q8h × 7 days</td>
<td stylecode="Rrule Toprule">750 mg q8h × 14 days</td>
<td stylecode="Rrule Toprule">12</td>
<td stylecode="Rrule Toprule">↑107%<br/>(↑83–↑135%)</td>
<td stylecode="Rrule Toprule">↑88%<br/>(↑66–↑113%)</td>
<td stylecode="Rrule Toprule">↑136%<br/>(↑103–↑175%)</td>
</tr>
<tr stylecode="Botrule">
<td colspan="6" stylecode="Lrule Rrule">Anti-infective Agents</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule">Ketoconazole 400 mg qd × 7 days</td>
<td stylecode="Rrule">500 mg q8h × 5–6 days</td>
<td stylecode="Rrule">12</td>
<td stylecode="Rrule">↑35%<br/>(↑24–↑46%)</td>
<td stylecode="Rrule">↑25%<br/>(↑11–↑40%)</td>
<td stylecode="Rrule">↑14%<br/>(↓23–↑69%)</td>
</tr>
<tr>
<td rowspan="2" stylecode="Lrule Botrule Rrule">Rifabutin 150 mg qd × 8 days</td>
<td stylecode="Rrule">750 mg q8h × 7–8 days</td>
<td stylecode="Rrule">11</td>
<td stylecode="Rrule">↓23%<br/>(↓14–↓31%)</td>
<td stylecode="Rrule">↓18%<br/>(↓8–↓27%)</td>
<td stylecode="Rrule">↓25%<br/>(↓8–↓39%)</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Rrule">1250 mg q12h × 7–8 days</td>
<td align="center" stylecode="Rrule">11</td>
<td stylecode="Rrule">↔</td>
<td stylecode="Rrule">↔</td>
<td stylecode="Rrule">↓15%<br/>(↓43–↑27%)</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule">Rifabutin 300 mg qd × 8 days</td>
<td stylecode="Rrule">750 mg q8h × 7–8 days</td>
<td stylecode="Rrule">10</td>
<td stylecode="Rrule">↓32%<br/>(↓15–↓46%)</td>
<td stylecode="Rrule">↓24%<br/>(↓10–↓36%)</td>
<td stylecode="Rrule">↓53%<br/>(↓15–↓73%)</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule">Rifampin 600 mg qd × 7 days</td>
<td stylecode="Rrule">750 mg q8h × 5–6 days</td>
<td stylecode="Rrule">12</td>
<td stylecode="Rrule">↓83%<br/>(↓79–↓86%)</td>
<td stylecode="Rrule">↓76%<br/>(↓69–↓82%)</td>
<td stylecode="Rrule">↓92%<br/>(↓86–↓95%)</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule">Azithromycin 1200 mg Single Dose</td>
<td stylecode="Rrule">750 mg tid × 9 days</td>
<td stylecode="Rrule">12</td>
<td stylecode="Rrule">↓15%<br/>(↓7–↓22%)</td>
<td stylecode="Rrule">↓10%<br/>(↓19–↑1%)</td>
<td stylecode="Rrule">↓29%<br/>(↓19–↓38%)</td>
</tr>
<tr stylecode="Botrule">
<td colspan="6" stylecode="Lrule Rrule">HMG-CoA Reductase Inhibitors</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule">Atorvastatin 10 mg qd × 28 days</td>
<td stylecode="Rrule">1250 mg bid × 14 days</td>
<td stylecode="Rrule">15</td>
<td colspan="3" stylecode="Rrule">See footnote <footnoteref idref="t6ft1"></footnoteref>
</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule">Simvastatin 20 mg qd × 28 days</td>
<td stylecode="Rrule">1250 mg bid × 14 days</td>
<td stylecode="Rrule">16</td>
<td colspan="3" stylecode="Rrule">See footnote <footnoteref idref="t6ft1"></footnoteref>
</td>
</tr>
<tr stylecode="Botrule">
<td colspan="6" stylecode="Lrule Rrule">Other Agents</td>
</tr>
<tr>
<td stylecode="Lrule Rrule">Methadone 80 mg + / - 21 mg qd &gt; 1 month</td>
<td stylecode="Rrule">1250 mg bid × 8 days</td>
<td stylecode="Rrule">13</td>
<td colspan="3" stylecode="Rrule">See footnote <footnoteref idref="t6ft1"></footnoteref>
</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule Toprule">Phenytoin 300 mg qd × 7 days</td>
<td stylecode="Rrule Toprule">1250 mg bid × 14 days</td>
<td stylecode="Rrule Toprule">15</td>
<td stylecode="Rrule Toprule">↔</td>
<td stylecode="Rrule Toprule">↔</td>
<td stylecode="Rrule Toprule">↓18%<br/>(↓45–↑23%)</td>
</tr>
<tr>
<td stylecode="Lrule Rrule">Omeprazole 40 mg qd × 4 days administered 30 minutes before nelfinavir</td>
<td stylecode="Rrule">1250 mg bid × 4 days</td>
<td stylecode="Rrule">19</td>
<td stylecode="Rrule">↓36%<br/>(↓20–↓49%)</td>
<td stylecode="Rrule">↓37%<br/>(↓23–↓49%)</td>
<td stylecode="Rrule">↓39%<br/>(↓15–↓57%)</td>
</tr>
</tbody>
</table>